{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T00:52:38Z","timestamp":1794185558198,"version":"4.8.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Eye Institute","award":["Grant #1R43EY025508-03"],"award-info":[{"award-number":["Grant #1R43EY025508-03"]}],"id":[{"id":"https:\/\/ror.org\/03wkg3b53","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate the safety and efficacy of multiwavelength photobiomodulation (PBM) in nonexudative (dry) age-related macular degeneration (AMD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>LIGHTSITE III used a double-masked, randomized, sham-controlled, parallel-group, prospective study design. Subjects were enrolled with a diagnosis of dry AMD and treated with multiwavelength PBM (Valeda Light Delivery System; 590, 660, and 850 nm) or sham treatment. A treatment series included 9 PBM or sham treatments delivered 3x\/week over 3 to 5 weeks every 4 months (M) for 24M.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 148 eyes (100 subjects) with dry AMD were randomized into the study. LIGHTSITE III met the prespecified primary BCVA efficacy end point at M21 with a significant difference between treatment groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0036) and a +6.2 letter gain after PBM. At M21, 61.5% of PBM-treated eyes showed \u22655, 23.1% showed \u226510, and 4.4% showed \u226515 letter gains. A favorable safety profile was observed with no signs of phototoxicity. Disease progression to Geographic Atrophy (GA) showed a significant decrease in incidence (Sham, 24.0% vs. PBM, 6.8%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.007) after PBM treatment at M24. Significant benefit in vision QoL was observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Multiwavelength PBM represents an interventional therapy that restores visual function and has potential disease-modifying effects in intermediate dry AMD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004822","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:00:10Z","timestamp":1772834410000},"page":"783-795","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["LONG-TERM EFFICACY AND SAFETY OF PHOTOBIOMODULATION IN DRY AGE-RELATED MACULAR DEGENERATION (LIGHTSITE III: 24-MONTH ANALYSIS)"],"prefix":"10.1097","volume":"46","author":[{"given":"Glenn J.","family":"Jaffe","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Duke University, Durham, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boyer","sequence":"additional","affiliation":[{"name":"Retina Vitreous Associates Medical Group, Beverly Hills, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Hu","sequence":"additional","affiliation":[{"name":"Cumberland Valley Retina ConsultantsHagerstown, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Warrow","sequence":"additional","affiliation":[{"name":"Cumberland Valley Retina ConsultantsChambersburg, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Xavier","sequence":"additional","affiliation":[{"name":"Florida Eye Clinic, Altamonte Springs, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Valley Retina Institute, McAllen, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Lad","sequence":"additional","affiliation":[{"name":"Department of OphthalmologyDuke University Medical Center, Durham, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Rosen","sequence":"additional","affiliation":[{"name":"New York Ear and Eye Infirmary of Mount Sinai, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana V.","family":"Do","sequence":"additional","affiliation":[{"name":"Byers Eye Institute, Stanford University, Palo Alto, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Schneiderman","sequence":"additional","affiliation":[{"name":"Pacific Northwest Retina, Silverdale, Washington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen C.","family":"Ho","sequence":"additional","affiliation":[{"name":"Wills Eye Hospital and Mid Atlantic Retina, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion R.","family":"Munk","sequence":"additional","affiliation":[{"name":"Augenarzt-Praxisgemeinschaft Gutblick AG, Bern, Switzerland;"},{"name":"Department of OphthalmologyInselspital, University Hospital Bern, Bern, Switzerland;,"},{"name":"Department of OphthalmologyFeinberg School of Medicine, Northwestern University, Chicago, Illinois;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Tedford","sequence":"additional","affiliation":[{"name":"LumiThera, Inc., Poulsbo, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy L.","family":"Croissant","sequence":"additional","affiliation":[{"name":"LumiThera, Inc., Poulsbo, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"R\u00fcckert","sequence":"additional","affiliation":[{"name":"LumiThera, Inc., Poulsbo, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip T.","family":"Lavin","sequence":"additional","affiliation":[{"name":"Boston Biostatistics Research Foundation, Framingham, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark E.","family":"Tedford","sequence":"additional","affiliation":[{"name":"LumiThera, Inc., Poulsbo, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/jbio.201670113","article-title":"Photobiomodulation or low-level laser therapy","volume":"9","author":"Hamblin","year":"2016","journal-title":"J Biophotonics"},{"key":"R2-20260915","first-page":"49","article-title":"Low-level light therapy of the eye and brain","volume":"3","author":"Rojas","year":"2011","journal-title":"Eye Brain"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s10439-011-0454-7","article-title":"The nuts and bolts of low-level laser (Light) therapy","volume":"40","author":"Chung HD","year":"2012","journal-title":"Ann Biomed Eng"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"7000417","DOI":"10.1109\/JSTQE.2016.2561201","article-title":"Proposed mechanisms of photobiomodulation or low-level light therapy","volume":"22","author":"de Freitas","year":"2016","journal-title":"IEEE J Sel Top Quan Electron"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archopht.1964.00970020794009","article-title":"Retinal oxygen utilization measured by hyperbaric blackout","volume":"72","author":"Anderson","year":"1964","journal-title":"Arch Ophthalmol"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/cns.13116","article-title":"Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure","volume":"25","author":"Wang","year":"2019","journal-title":"CNS Neurosci Ther"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/dj8030087","article-title":"Photobiomodulation and oral mucositis: a systematic review","volume":"8","author":"Cronshaw","year":"2020","journal-title":"Dent J (Basel)"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10571-020-01016-9","article-title":"The molecular mechanisms of action of photobiomodulation against neurodegenerative diseases: a systematic review","volume":"42","author":"Bathini","year":"2022","journal-title":"Cell Mol Neurobiol"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s13534-019-00115-x","article-title":"Photobiomodulation as a treatment for neurodegenerative disorders: current and future trends","volume":"9","author":"Hong","year":"2019","journal-title":"Biomed Eng Lett"},{"key":"R10-20260915","first-page":"145","article-title":"Photobiomodulation for the treatment of retinal diseases: a review","volume":"9","author":"Geneva","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11882-019-0869-z","article-title":"Laser light therapy in inflammatory, musculoskeletal, and autoimmune disease","volume":"19","author":"Wickenheisser","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"1388602","DOI":"10.3389\/fopht.2024.1388602","article-title":"Photobiomodulation use in ophthalmology - an overview of translational research from bench to bedside","volume":"4","author":"Valter","year":"2024","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s40123-022-00640-6","article-title":"LIGHTSITE II randomized multicenter trial: evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration","volume":"12","author":"Burton","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/medicina58111662","article-title":"Effects of photobiomodulation in patients presenting with reticular pseudodrusen: a retrospective observational case series study","volume":"58","author":"Le","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/IAE.0000000000002632","article-title":"A double-masked, randomized, sham-controlled, single-center study with photobiomodulation for the treatment of dry age-related macular degeneration","volume":"40","author":"Markowitz","year":"2020","journal-title":"Retina"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/IAE.0000000000003980","article-title":"Lightsite III: 13-month efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative (Dry) age-related macular degeneration using the LumiThera valeda light delivery system","volume":"44","author":"Boyer","year":"2023","journal-title":"Retina"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2013.03.009","article-title":"Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration","volume":"59","author":"Finger","year":"2014","journal-title":"Surv Ophthalmol"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2147\/OPTH.S100764","article-title":"Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials","volume":"10","author":"Dugel","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40123-022-00583-y","article-title":"Dry age-related macular degeneration: distribution of visual acuity and progression risk in a large registry","volume":"12","author":"Leng","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ophtha.2019.12.009","article-title":"Natural history of geographic atrophy secondary to age-related macular degeneration: results from the prospective proxima A and B clinical trials","volume":"127","author":"Holekamp","year":"2020","journal-title":"Ophthalmology"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1167\/iovs.17-22528","article-title":"Association of low luminance questionnaire with objective functional measures in early and intermediate age-related macular degeneration","volume":"59","author":"Thompson","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/IAE.0000000000003805","article-title":"Photobiomodulation therapy for large soft drusen and drusenoid pigment epithelial detachment in age-related macular degeneration: a single-center prospective pilot study","volume":"43","author":"Benlahbib","year":"2023","journal-title":"Retina"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1038\/s41433-024-03326-4","article-title":"Short-term efficacy of photobiomodulation in early and intermediate age-related macular degeneration: the PBM4AMD study","volume":"38","author":"Nassisi","year":"2024","journal-title":"Eye (Lond)"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.2147\/OPTH.S415883","article-title":"Non-invasive treatment of early diabetic macular edema by multiwavelength photobiomodulation with the valeda light delivery system","volume":"17","author":"Kaymak","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s40123-024-00963-6","article-title":"Improvement in central serous chorioretinopathy following multiwavelength photobiomodulation treatment - case report","volume":"13","author":"Sachdev","year":"2024","journal-title":"Ophthalmol Ther"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.2147\/OPTH.S483722","article-title":"Short-term results of multiwavelength photobiomodulation in retinitis pigmentosa","volume":"18","author":"Siqueira","year":"2024","journal-title":"Clin Ophthalmol"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jad.2018.09.048","article-title":"Transcranial and systemic photobiomodulation for major depressive disorder: a systematic review of efficacy, tolerability and biological mechanisms","volume":"243","author":"Caldieraro","year":"2019","journal-title":"J Affect Disord"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1002\/cam4.3582","article-title":"Safety and efficacy of photobiomodulation therapy in oncology: a systematic review","volume":"9","author":"Bensadoun","year":"2020","journal-title":"Cancer Med"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.oraloncology.2019.04.004","article-title":"Tumor safety and side effects of photobiomodulation therapy used for prevention and management of cancer treatment toxicities. A systematic review","volume":"93","author":"de Pauli Paglioni","year":"2019","journal-title":"Oral Oncol"},{"key":"R34-20260915","first-page":"6891","article-title":"Long-term safety of photobiomodulation therapy for oral mucositis in hematopoietic cell transplantation patients: a 15-year retrospective study","volume":"29","author":"Bezinelli","year":"2021","journal-title":"Support Care Cancer"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.oret.2021.10.003","article-title":"A randomized trial of photobiomodulation therapy for center-involved diabetic macular edema with good visual acuity (Protocol AE)","volume":"6","author":"Kim","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"R36-20260915","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","article-title":"Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial","volume":"37","author":"Patel","year":"2023","journal-title":"Eye (Lond)"},{"key":"R37-20260915","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:00:49Z","timestamp":1789491649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004822","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}